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ABSTRACT
Objectives: We examined whether obesity based on
body mass index (BMI) was a predictor of functional
independence measure (FIM) at 6 months after
ischaemic stroke onset while adjusting for stroke
risk factors and covariates and stratifying by age
group.
Design: This is an interim report of the Korean
Stroke Cohort for Functioning and Rehabilitation that
was designed as a nested case study within a
nationwide hospital-based cohort.
Setting: We identified all patients who were admitted
to nine representative hospitals in Korea from 2012
until 2014 under a diagnosis of acute first-ever
ischaemic stroke. The hospitals were selected from
the metropolitan district, mid-sized cities and a small-
sized city.
Participants: The sample included 2057 patients
with acute ischaemic stroke who were at least 18 years
old.
Primary and secondary outcome measures: We
divided participants into two age levels (<65 and
≥65 years). Participants were classified into five
groups according to their baseline BMI at admission:
underweight (BMI<18.5), normal (18.5≤BMI<23),
overweight (23≤BMI<25), obese (25≤BMI<30) and
extremely obese (30≤BMI).
Results: The proportion of patients who were aged
≥65 years was 55.0%. The proportions of
underweight, normal, overweight, obese and
extremely obese patients were 2.6%, 24.3%, 29.6%,
37.2% and 6.3%, respectively, in the <65 years
group and 5.5%, 34.5%, 27.9%, 28.8% and 3.3%,
respectively, in the ≥65 years group. In a multiple
linear regression, the 6-month FIM after stroke in
the elderly group was significantly associated with
being extremely obese (7.95, p<0.05) after adjusting
for confounding variables. In the <65 years group,
the 6-month FIM was not associated with any
weight category.
Conclusions: This nationwide hospital-based cohort
study showed that extreme obesity is a predictor
of a good 6-month FIM, especially in patients
with ischaemic stroke who are at least 65 years
of age.
INTRODUCTION
The prevalence of obesity in Korea was shown
to be 32.5% among individuals aged 20 years
or older (32.2% in those aged 20–64 years
and 34.3% in those over 65 years) in the 2013
Korea National Health and Nutrition
Examination Survey.1 Obesity is one of the
leading risk factors for cardiovascular
disease.2 However, obese and overweight
patients undergoing acute rehabilitation
showed higher functional outcomes than did
patients in a normal weight range based on
body mass index (BMI).3 Obesity is also
known to be a good predictor of functional
outcomes in patients with ischaemic stroke,4
especially elderly patients.5 Furthermore,
post-stroke mortality is inversely related to
BMI: overweight and obese patients with
stroke had a lower post-stroke mortality rate
than normal-weight and underweight patients
in a study from Denmark.6
Functional outcomes such as the func-
tional independence measurement (FIM)
are used to evaluate the ability of individuals
to perform activities of daily living.
Functional outcomes in patients with ischae-
mic stroke sharply increase from 2 to
Strengths and limitations of this study
▪ Patients with stroke who were extremely obese
performed activities of daily living better than did
patients with a normal body mass index among
patients aged 65 years or older. However, the
6-month functional independence measure (FIM)
was not associated with any weight category in
the under 65 age group.
▪ The FIM was evaluated for daily living activities.
▪ Participants’ heights and weights were measured
once on admission to our study.
▪ We did not account for the proportions and dis-
tributions of muscle, bone and adipose tissue in
obese patients in this study.
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6 months after the stroke, and ability of daily living
(ADL) was recovered slowly in the chronic stage
6 months after the stroke.7 However, few studies have
analysed functional outcomes in relation to obesity at
6 months post-stroke. Therefore, we examined whether
obesity based on BMI was predictive of the 6-month
post-stroke FIM after adjustment for gender, education,
smoking, drinking, hypertension (HT), diabetes mellitus
(DM), dyslipidaemia, chronic kidney disease (CKD), dis-
charge FIM, and 7-day National Institutes of Health
Stroke Scale (NIHSS) score and stratiﬁcation by two age
groups: less than 65 years and greater than or equal to
65 years.
METHODS
This is an interim report of the Korean Stroke Cohort
for Functioning and Rehabilitation (KOSCO). We identi-
ﬁed all patients of at least 18 years of age who were
admitted to nine representative hospitals in Korea
under a diagnosis of acute ﬁrst-ever stroke, either ischae-
mic or haemorrhagic, from January 2012 until October
2014. The hospitals were selected from the metropolitan
district (Samsung Medical Center, Yonsei University
Hospital, and Konkuk University Hospital), mid-sized
cities (Chungnam National University Hospital, Pusan
National University Hospital, Chonnam National
University Hospital, Wonkwang University Hospital, and
Kyung-pook National University Hospital), and a small-
sized city ( Jeju University Hospital). Patients with acute
stroke were deﬁned as those experiencing ischaemic or
haemorrhagic stroke who were admitted within 7 days of
the onset of stroke symptoms. Patients experiencing a
transient ischaemic attack (TIA) or who were admitted
more than 7 days after symptom onset were excluded.
TIA was deﬁned as symptoms resolving within 24 h of
onset and no evidence of acute infarction by brain CT
or MRI. The medical records of all participants were
reviewed by well-trained rehabilitation specialists. The
study protocol was approved by the Samsung Medical
Center Institutional Review Board.
The nationwide hospital-based cohort study popula-
tion included 2057 patients with ischaemic stroke aged
18 years or older. We divided participants into two age
groups: less than 65 years (young and middle-aged;
45%) and greater than or equal to 65 years (elderly;
55.0%). The mean age was 54.2 (±8.16) years in the
young and middle-aged patients and 74.8 (±5.98) years
in the elderly patients. The proportions of males in
these groups were 70.5% and 56.1%, respectively (see
online supplementary table S1). Education level was
classiﬁed into three categories: (1) elementary school:
elementary school or 6 years or less of schooling, (2)
middle/high school: middle school or 7–12 years of
schooling, and (3) college/university: college or
>12 years of schooling. A participant was deﬁned as a
current drinker if he/she had consumed an alcoholic
drink within 1 year of the survey date. Functional status
was assessed at discharge and at 6 months after stroke
onset in the KOSCO study. In a multiple linear regres-
sion analysis, we used the FIM at discharge to assess
the initial ADL status. The FIM scale consisted of 13
physical and 5 cognitive disability items, such as inde-
pendent eating; grooming; bathing/showering; dressing
the upper or lower body; using the toilet; bladder or
bowel control; 5 different mobility abilities; communica-
tion including expression and comprehension; psycho-
social ability; and cognition, including problem-solving
and memory. Each item was scored from one to seven
based on the patient’s level of independence, with one
representing total dependence and seven representing
complete independence. Possible total scores ranged
from 18 to 126, with higher scores indicating greater
independence. We assessed stroke severity using the
NIHSS at 7 days after stroke onset. The NIHSS is com-
posed of 11 items: level of consciousness, gaze, visual
ﬁeld, facial palsy, movement of arms and legs, limb
ataxia, sensory loss, language, dysarthria, and extinction
and inattention. The score of each speciﬁc ability
ranges from 0 to 4. Possible total scores range from 0
to 42, with higher scores indicative of some level of
impairment.
Obesity
BMI was calculated as weight in kilograms divided by the
square of height in metres. We measured each partici-
pant’s standing height using anthropometry. The patient
stood with the heels together and toes apart and the
back of the head, buttocks and heels in contact with the
backboard. The head was aligned in the Frankfort hori-
zontal plane. We measured height to one decimal point
(cm) with an anthropometric bar on the participant’s
head. Participants were weighed in kilograms using a
scale when gradation had stabilised after setting the
scale to zero with no load. Participants were classiﬁed
into ﬁve groups based on their baseline BMI at admis-
sion: underweight (BMI<18.5), normal (18.5≤BMI<23),
overweight (23≤BMI<25), obese (25≤BMI<30), and
extremely obese (30≤BMI).8 9
Stroke risk factors
We assessed stroke risk factors such as HT, DM, dyslipi-
daemia, CKD and smoking status. Participants were
deﬁned as having HT if they were taking an anti-HT
drug, had been clinically diagnosed with hypertension,
or had either a systolic blood pressure (SBP)
≥140 mm Hg or a diastolic blood pressure (DBP)
≥90 mm Hg. Participants who met one of the following
requirements were deﬁned as having DM: taking an oral
hyperglycaemic agent, using insulin, having received a
clinical diagnosis of diabetes, or having a fasting glucose
level >126 mg/dL. Participants were deﬁned as having
dyslipidaemia if they met one of the following require-
ments: diagnosis of hypercholesterolaemia, medication
history for hypercholesterolaemia, total cholesterol (TC)
>200 mg/dL, or low density lipoprotein (LDL)
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Table 1 Distribution of general characteristics, stroke risk factors and covariates by age group and weight group based on
body mass index (n=2057)*
Variables
Underweight
(n=86)
Normal
(n=616)
Overweight
(n=590)
Obese
(n=670)
Extremely
obese (n=95)
<65 years old (n=925) n=24 n=225 n=274 n=344 n=58
Body mass index† 17.2±1.12 21.0±1.01 23.5±0.50 26.4±1.29 32.0±2.87
Age, years† 52.0±9.18 53.7±8.44 56.1±7.07 53.9±8.04 50.5±10.1
Gender, male 54.1 67.5 73.3 70.6 74.1
Smoking
Ex 4.2 12.0 12.4 13.9 15.5
Current 54.1 44.4 47.0 33.3 36.2
Drinking, current 54.1 47.1 50.7 52.3 50.0
Education
College/university 33.3 31.2 23.0 32.7 29.8
Middle/high school 58.3 58.8 61.2 56.8 54.4
Elementary 8.4 10.0 15.8 10.5 15.8
Hypertension† 58.3 68.0 77.3 88.6 84.4
Diabetes mellitus 50.0 42.2 48.5 52.9 60.3
Dyslipidaemia† 25.0 30.2 45.2 43.3 55.1
CKD‡ 16.6 3.5 3.6 5.3 8.6
Taking a medicine, yes
Anti-hypertensive agent† 29.1 22.2 35.4 37.7 37.9
Anti-DM agent 20.8 11.1 13.8 17.4 17.2
Lipid lowering agent 0.0 4.4 8.0 8.7 8.6
SBP, mm Hg† 131.9±23.8 144.7±27.0 147.9±27.8 154.4±27.4 156.8±37.2
DBP, mm Hg† 79.5±14.9 85.1±16.1 87.4±14.7 90.1±17.1 90.8±24.6
FBS, mg/dL 139.9±68.1 140.9±80.2 137.3±56.8 143.5±60.5 158.3±78.6
TC, mg/dL‡ 172.1±36.0 181.1±43.4 188.2±44.5 193.7±47.6 197.7±47.4
TG, mg/dL‡ 128.9±152.4 117.8±79.4 139.4±102.6 154.5±112.4 163.4±124.1
HDL, mg/dL‡ 47.5±18.5 48.4±15.0 46.0±11.4 45.0±12.9 43.4±10.9
LDL, mg/dL† 95.9±25.0 108.8±35.9 122.2±44.5 121.6±37.2 136.4±85.9
Creatinine, mg/dL 1.06±1.10 0.90±1.24 0.87±0.62 0.86±0.45 0.99±0.86
eGFR, mL/min/1.73 m2 93.2±32.1 96.8±19.1 94.1±17.9 94.1±19.6 93.9±23.3
FIM, discharge 94.8±31.6 105.7±22.3 105.6±23.3 106.7±23.0 106.4±26.1
FIM, 6 months‡ 108.4±27.3 118.1±16.2 116.7±20.5 118.9±18.1 120.6±16.1
NIHSS, 7-day 4.38±5.68 3.16±5.01 2.94±4.80 2.55±4.36 2.40±3.74
≥65 years old (n=1132) n=62 n=391 n=316 n=326 n=37
Body mass index† 17.4±0.90 20.8±1.05 23.5±0.50 26.2±1.26 31.7±2.67
Age, years† 79.1±5.65 75.7±6.20 74.3±5.57 73.6±5.66 72.6±5.35
Gender, male‡ 35.4 58.8 58.8 55.5 45.9
Smoking
Ex 14.5 17.1 18.6 18.7 13.5
Current 19.3 19.4 16.1 16.2 5.4
Drinking, current 19.3 31.2 24.0 32.2 27.0
Education
College/university 1.6 10.8 12.9 12.8 18.9
Middle/high school 47.5 36.5 39.7 42.8 32.4
Elementary 50.9 52.7 47.4 44.4 48.7
Hypertension‡ 85.4 87.2 86.7 92.9 97.3
Diabetes mellitus 46.7 53.2 56.6 57.6 67.5
Dyslipidaemia 20.9 28.9 31.3 32.2 37.8
CKD 29.5 16.7 20.1 18.6 16.6
Taking a medicine, yes
Anti-hypertensive agent† 32.2 51.9 51.5 60.7 83.7
Anti-DM agent 19.3 23.7 21.5 27.6 40.5
Lipid lowering agent‡ 4.8 8.4 14.8 12.8 18.9
SBP, mm Hg 152.2±32.0 148.9±25.4 148.1±28.8 151.2±26.2 148.6±25.9
DBP, mm Hg 81.0±18.9 82.0±12.9 82.0±14.4 83.2±14.5 81.0±12.9
Continued
Jang SY, et al. BMJ Open 2015;5:e008712. doi:10.1136/bmjopen-2015-008712 3
Open Access
>130 mg/dL. The estimated glomerular ﬁltration rate
(eGFR), used as an indicator of kidney function, was cal-
culated using the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equation.10 The CKD-EPI
equation is as follows: GFR=141×min (serum Cr/κ,
1)α×max (serum Cr/κ, 1)−1.209×0.993Age×1.018 (if
female), where κ is 0.7 for females and 0.9 for males, α
is −0.329 for females and −0.411 for males, min indi-
cates the smaller value of serum Cr/κ or 1, and max
indicates the larger value of serum Cr/κ or 1. The
National Kidney Foundation Kidney Disease Outcome
Quality Initiative deﬁnes CKD as an eGFR <60 mL/min/
1.73 m2. A participant was identiﬁed as a current smoker
if he/she had smoked within 1 year of the survey date.
Statistical analyses
Differences in general characteristics, clinical data and
covariates among obese patients were analysed using
Student’s t test or one-way analysis of variance for con-
tinuous variables and the χ2 test for categorical variables.
Multiple linear regressions using general linear models
with the 6-month FIM as the dependent variable and
obesity classiﬁcation, based on BMI, as the independent
variable were performed by age group after adjusting for
gender, HT, DM, dyslipidaemia, CKD, education,
smoking, drinking, FIM on discharge and 7-day NIHSS
score.
RESULTS
The proportions of underweight, normal, overweight,
obese and extremely obese patients were 2.6%, 24.3%,
29.6%, 37.2% and 6.3%, respectively, in the under 65
age group and 5.5%, 34.5%, 27.9%, 28.8% and 3.3%,
respectively, in the 65 years or older group. For drinking,
the proportion by obese classiﬁcation was about 50% in
young and middle-aged patients and about 20–30% in
elderly patients. The proportions of antihypertensive
agent, anti-DM agent and lipid lowering agent were
about 20–40%, 10–20% and 0–10%, respectively, in
young and middle-aged patients and about 30–80%, 20–
40% and 5–20%, respectively, in elderly patients. Among
young and middle-aged patients, the mean FIMs at
6 months after a stroke for underweight, normal, over-
weight, obese and extremely obese individuals were
108.4 (±27.3), 118.1 (±16.2), 116.7 (±20.5), 118.9
(±18.1) and 120.6 (±16.1), respectively (p<0.05). Among
elderly patients, the mean FIMs at 6 months after a
stroke for the same weight categories were 93.0 (±38.4),
100.4 (±33.2), 104.2 (±32.0), 106.5 (±29.7) and 111.6
(±27.8), respectively (p=non-signiﬁcant) (table 1).
In a multiple linear regression, the 6-month FIM after
stroke in the elderly group was signiﬁcantly associated
with being extremely obese (7.95, p<0.05) after adjusting
for confounding variables. The 6-month FIM was not
associated with any weight category in the young and
middle-aged group (table 2).
DISCUSSION
A higher FIM at 6 months after stroke onset was asso-
ciated with extreme obesity in the 65 years and older
age group. Our ﬁnding is similar to that of the
Telemedical Project for Integrative Stroke Care
(TEMPiS) trial. The TEMPiS trial included 4428 elderly
patients with acute stroke or TIA and showed that over-
weight and obese patients had improved survival and
better combined outcomes of survival and non-fatal
functional status than did normal-weight patients.11
Among the 819 patients admitted to an acute rehabilita-
tion hospital for stroke rehabilitation, overweight
patients also had better FIMs than did patients in the
other weight categories.4 Ovbiagele et al12 showed that
obese patients with stroke have a lower overall vascular
risk than do their leaner counterparts. Furthermore, the
Atherosclerosis Risk in Communities (ARIC) study con-
ﬁrmed a positive and linear relationship between BMI
and ischaemic stroke incidence,13 and overweight and
Table 1 Continued
≥65 years old (n=1132) n=62 n=391 n=316 n=326 n=37
FBS, mg/dL 138.7±67.2 142.2±65.8 144.3±65.7 143.4±56.6 136.5±44.6
TC, mg/dL 176.5±43.0 174.3±39.2 176.0±37.0 175.7±41.7 172.9±49.1
TG, mg/dL† 88.1±41.8 104.8±63.2 111.6±60.8 127.3±77.6 113.6±60.1
HDL, mg/dL† 50.6±13.7 47.4±13.2 44.9±13.3 43.4±11.2 48.7±11.6
LDL, mg/dL 110.2±46.2 107.6±33.4 109.1±32.8 110.4±46.2 112.5±36.5
Creatinine, mg/dL 1.09±1.72 1.08±1.48 0.95±0.57 0.94±0.40 0.86±0.29
eGFR, mL/min/1.73 m2 72.4±21.3 75.9±20.3 75.6±18.8 74.3±17.9 77.4±16.8
FIM, discharge 81.8±32.8 89.3±31.4 93.1±31.2 95.4±29.3 93.1±31.7
FIM, 6 months 93.0±38.4 100.4±33.2 104.2±32.0 106.5±29.7 111.6±27.8
NIHSS, 7-day‡ 4.95±5.89 4.67±6.06 4.08±6.08 3.49±5.48 3.76±7.82
†p<0.001; ‡p<0.05.
*Analysis of variance or χ2 test.
CKD, chronic kidney disease; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; FBS, fasting
blood sugar; FIM, functional independence measure; HDL, high density lipoprotein; LDL, low density lipoprotein; NIHSS, National Institutes of
Health Stroke Scale; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
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obese patients who survived the ﬁrst event tended to
subsequently have improved cardiovascular disease14 15
and cerebrovascular disease burdens.16 17
Although the obesity paradox18 indicates that obese
patients receive better treatment and care because they
are perceived to be at high risk,19 Ryu et al20 have pro-
posed that the obesity paradox phenomenon has limita-
tions and that there might not be a direct causal
relationship between obesity and improved treatment
and care due to the association of long-term mortality
with initial neurological severity in patients with ischae-
mic stroke in Korea. Obesity increases the bone mineral
density and decreases osteoporosis and hip fractures in
the elderly.21 Bamia et al22 showed that the body weight
of elderly individuals was reported to be an independent
protecting factor against femoral osteoporosis.
Furthermore, among the 1077 patients admitted to an
acute rehabilitation hospital in the USA, motor FIM
scores increased from admission to discharge in the
obese (BMI 30.0–34.9) group.3 Our results also showed
that the 6-month FIMs gradually increased as weight cat-
egory increased from underweight to extremely obese in
both age groups. For this reason, the ﬁnding that
obesity is a good predictor for the 6-month FIM was not
surprising in this study.
Strazzullo et al23 observed that being overweight or
obese is associated, at least in part, with a progressively
increasing risk of ischaemic stroke and that this associ-
ation is independent of age, lifestyle and other cardio-
vascular risk factors. Additionally, the China National
Stroke Registry shows that severe obesity is independ-
ently associated with higher 3-month mortality.24
However, Jee et al showed that the mortality rate did
not increase for elderly Korean individuals with a BMI
of 25 or higher. The effect of obesity on mortality in
the elderly can be inﬂuenced by various parameters
such as existing diseases.25 These results do not indi-
cate that obesity is less harmful to the elderly than to
younger people. We believe that if elderly patients
with stroke utilise resistance exercises and proper
diets, increased muscle mass and reduced body fat
could be expected during a successful stroke
rehabilitation.
This study has several limitations. First, it was con-
ducted prospectively with a multicentre design, which
may have impacted data reliability. To counteract this
problem, the KOSCO committee leads a training
course for rehabilitation specialists twice a year.
Second, height and weight were measured once at
admission to our study. Third, we did not account for
the proportions and distributions of muscle, bone and
adipose tissue26 in obese patients in this study. Thus,
further cardiovascular cohort studies that consider
these variables are needed to verify the risk factors for
cerebrovascular accident.
CONCLUSION
Our study shows that extreme obesity is a predictor of
good functional outcomes in patients with ischaemic
stroke, especially elderly patients. The strength of this
study is the high degree of representation of Korean
patients with ischaemic stroke that was achieved. Our
results are thus applicable to the entire nation.
Table 2 Multiple linear regressions for 6 months FIM by age group*
<65 years old ≥65 years old
Variables β (95% CI) p Value β (95% CI) p Value
Weight categories
Underweight −3.81 (−8.93 to 1.31) 0.145 −2.53 (−7.74 to 2.67) 0.340
Normal 1.0 1.0
Overweight −1.19 (−3.35 to 0.97) 0.280 1.17 (−1.67 to 4.02) 0.420
Obese 0.05 (−2.05 to 2.15) 0.962 0.76 (−2.07 to 3.61) 0.596
Extremely obese 1.66 (−1.87 to 5.20) 0.355 7.95 (1.41 to 14.4) 0.017
Gender, female vs male 0.27 (−1.86 to 2.41) 0.800 −1.00 (−3.92 to 1.91) 0.501
Education
College/university 1.0 1.0
Middle/high school −1.61 (−3.39 to −0.16) 0.074 1.79 (−1.67 to 5.26) 0.310
Elementary −0.38 (−3.12 to 2.35) 0.783 1.65 (−1.89 to 5.20) 0.360
Smoking, current 0.38 (−0.65 to 1.42) 0.467 0.64 (−1.10 to 2.38) 0.469
Drinking, current 1.37 (−0.42 to 3.17) 0.133 1.34 (−1.51 to 4.20) 0.356
Hypertension, yes −0.20 (−2.19 to 1.78) 0.841 −0.03 (−3.65 to 3.58) 0.984
Diabetes mellitus, yes −0.73 (−2.31 to 0.85) 0.364 −0.68 (−2.96 to 1.59) 0.556
Dyslipidaemia, yes −0.42 (−2.04 to 1.19) 0.610 −0.33 (−2.80 to 2.14) 0.792
Chronic kidney disease −3.35 (−7.03 to 0.33) 0.075 −3.48 (−6.37 to −0.62) 0.017
FIM, discharge 0.36 (0.31 to 0.41) <0.001 0.53 (0.47 to 0.58) <0.001
NIHSS, 7-day −1.33 (−1.56 to −1.10) <0.001 −1.82 (−2.10 to −1.58) <0.001
*Estimated by multiple linear regression models using the variables in the table.
FIM, functional independence measure; NIHSS, National Institutes of Health Stroke Scale.
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